News roundup

Critically ill men in drug trial continue to improve

London Susan Mayor

One of the two men left critically ill by a phase I trial of a new monoclonal antibody almost two weeks ago is improving, says the latest statement released by the hospital caring for him.

The statement, from the critical care department at Northwick Park Hospital, London, said, “The two volunteers have each made improvements since last week. One is in a serious condition. The other is still critical but we are pleased with his progress since last week. However, we remain cautious as his condition is still complex.” Staff said they were unable to comment further without breaching patient confidentiality.

The hospital said that the four other men involved in the trial were continuing to make a good recovery. “They continue to receive specialist care and observation, but have been discharged from critical care. They remain in hospital and are working on regaining their strength and . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Severe adverse reactions prompt call for trial design changes

Susan Mayor
BMJ 2006 332: 683. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

NHS costs of trial drug reactions

Patrick C Dubois, et al.
bmj.com, 6 Apr 2006 [Full text]